Amgen faces major revenue risk from upcoming patent cliffs but has promising pipeline drugs to offset losses. Learn why AMGN ...

Novartis and Amgen also boast impeccable dividend track records, which should please investors. When broader equities are ...

Shares of Amgen Inc. AMGN rallied 1.13% to $290.33 Friday, on what proved to be an all-around great trading session for the ...

Later this month, the Street will have a fresh opportunity to gauge the potential for Amgen's experimental weight-loss drug, MariTide.

The Humankind U.S. Stock ETF (HKND) struggles with diversification, average quality, and unproven strategies. Read an ...

Patent claims reciting compounds where at least one group of a compound genus is defined by its function are common. For ...

Wolfspeed bankruptcy watch, North Carolina lands more data centers, Duke University’s funding crunch, and an AI companion ...

The novel selective antibody sibeprenlimab reduced proteinuria more than any prior drug for IgA nephropathy, with excellent ...

Historically linked to an anti-duelling group, Daniel O’Connell and the East India Company, today properties on ‘the Green’ house the offices of global corportations, an online retail giant and ...

As President Trump touts his own executive orders to lower drug prices, the Medicare drug price negotiations begun during the Biden administration are continuing behind the scenes. Two companies – ...

The Puerto Rico Science, Technology and Research Trust and the National Institute for Innovation in Manufacturing ...

Columbus City Schools receive $740K to launch hands-on manufacturing programs, preparing students for Ohio’s high-demand STEM ...